MALT2: A Potential Drug Target and Biomarker (G23139)

Target Name: MAST2

NCBI ID: G23139

MAST2

MALT2: A Potential Drug Target and Biomarker

MAST2 (MutL homolog 2) is a gene that encodes a protein known as MALT2. MALT2 is a protein that is expressed in a variety of tissues and cells throughout the body, including the brain, spinal cord, and muscle. It is involved in the development and maintenance of tissues, including neurons and muscle cells.

One of the functions of MALT2 is its role in cell signaling. MALT2 has been shown to play a role in the regulation of cell proliferation and differentiation. It has also been shown to play a role in the development and maintenance of tissues, including neurons and muscle cells.

In addition to its role in cell signaling, MALT2 has also been shown to have potential as a drug target. Several studies have suggested that MALT2 may be a potential drug target for the treatment of various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the reasons for the potential of MALT2 as a drug target is its location in the genome. MALT2 is located on chromosome 18, which makes it a relatively stable gene that is less likely to be affected by genetic variations that could lead to its disappearance. This makes it a good candidate for a drug target that is located in a relatively stable location on the genome.

Another reason for the potential of MALT2 as a drug target is its involvement in the regulation of cell signaling. MALT2 has been shown to play a role in the regulation of cell proliferation and differentiation, which are important processes that are involved in the development and maintenance of tissues. This suggests that MALT2 may be a good candidate for a drug that can inhibit these processes, which could lead to the treatment of various diseases.

In addition to its potential as a drug target, MALT2 has also been shown to have potential as a biomarker. Several studies have suggested that MALT2 may be a good candidate for use as a biomarker for the diagnosis and prognosis of various diseases. This is because MALT2 is expressed in a variety of tissues and cells throughout the body, which makes it a good candidate for use as a biomarker.

Overall, MALT2 is a gene that has potential as a drug target and biomarker. Further research is needed to determine its full role in the development and maintenance of tissues, as well as its potential as a drug target and biomarker.

Protein Name: Microtubule Associated Serine/threonine Kinase 2

Functions: Appears to link the dystrophin/utrophin network with microtubule filaments via the syntrophins. Phosphorylation of DMD or UTRN may modulate their affinities for associated proteins. Functions in a multi-protein complex in spermatid maturation. Regulates lipopolysaccharide-induced IL-12 synthesis in macrophages by forming a complex with TRAF6, resulting in the inhibition of TRAF6 NF-kappa-B activation (By similarity)

The "MAST2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MAST2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets